U.S.-listed Taiwan Semiconductor Manufacturing Co. (TSM.US) ADRs are currently gaining 7% after the company reported record third-quarter net profit, driven by strong demand for smartphones and artificial intelligence chips. The world's largest chipmaker reported that quarterly net profit rose 54% year-on-year to 325.26 billion Taiwan dollars, equivalent to $10.10 billion. That topped analysts' consensus estimate of 298.00 billion Taiwan dollars. At the same time, TSMC's revenue was also a record, rising 39% to $759.69 billion Taiwan dollars for the quarter. After such strong results, the company decided to raise its earnings forecasts for the fourth quarter of this year and thus for the full year.
FOURTH QUARTER FORECAST
- Sales of $26.1 billion to $26.9 billion, $24.94 billion was expected
- Gross margin of 57% to 59%, expected 54.7%
- Operating margin 46.5% to 48.5%, expected 44.3%
THIRD QUARTER RESULTS
- Net income 325.3 billion Taiwan dollars, +54% y/y, expected 299.3 billion Taiwan dollars
- Gross margin 57.8% vs. 53.2% q/q, 54.8% expected
- Operating profit 360.77 billion Taiwan dollars, +58% y/y, 330.82 billion Taiwan dollars expected
- Operating margin 47.5% vs. 42.5% q/q, expected 44.6%
- Sales 759.69 billion Taiwan dollars, +39% y/y, 751.06 billion Taiwan dollars expected
OTHER IMPORTANT COMMENTS
- Sales in 2024 to grow nearly 30% in USD terms
- Company continues to see “extremely strong” demand related to artificial intelligence
In response to such strong results, the stock traded at new highs before Wall Street opened. Moreover, Nvidia (NVDA.US) shares are also up nearly 3%. Source: xStation
USA Rare Earth Acquires Key Brazilian Rare Earth Metal Mines โ๏ธ
US OPEN: Return of geopolitical concerns hits markets ๐ฅ
New Player in Googleโs Ecosystem? Marvell Triggers Market Reaction
Will Wall Street reach new record high?๐ฝHighlights from S&P 500 earnings season
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
